Patient P-01420

Synthetic patientNBL-101 · Day 109 · 25–34 · F · baseline S03Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Favorable

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

31%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S03

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability+11
Inflammatory activity+9
Nutritional resilience-8
Treatment adherence-4
Toxicity+3

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

25.9/100

worsening · +6.4 vs previous 14 d

Toxicity

Blood

14.3/100

worsening · +1.2 vs previous 14 d

Sleep quality

Wearable

28.3/100

worsening · -3.1 vs previous 14 d

Energy level

Daily log

6.6/10

worsening · -0.3 vs previous 14 d

Stress level

Daily log

5.2/10

worsening · +0.2 vs previous 14 d

Steps

Wearable

5,104

worsening · -275 vs previous 14 d

Adherence

Companion

89 %

worsening · -5.6 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 84 from the failing basin, 12 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Keep histamine low
GI +2.1 next day on high-intake days · n 14

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Histamine load
+2.1detractor · 57%
Insoluble fibre
+1.3no signal · 32%
Spicy / capsaicin
+0.7no signal · 17%
Simple carbohydrates
-0.5no signal · 15%
Dietary fat load
+0.4no signal · 15%
Alcohol
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↓45
- WearableResting HR 72 bpm
- WearableShort sleep window
Inflammatory signalling ↑35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 38 ms, trending down

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 4.5 · butyrate capacity 67/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 38 ms
Sleep: 6.2 h
Steps: 5,242
Resting HR: 71 bpm

Daily log: GI score 26, nutritional resilience 63, adherence 89.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01798	47%	S08	NP-02	improved	78
P-01654	46%	S08	CR-01	improved	85
P-01796	45%	S09	SC-12	improved	86
P-01329	44%	S08	BR-03	improved	79
P-01671	43%	S04	SC-12	improved	90
P-01495	42%	S07	BR-03	improved	85
P-01625	41%	S06	SC-12	improved	83
P-01439	40%	S18	ME-01	improved	79
P-01503	40%	S15	ME-01	improved	80
P-01791	39%	S06	ME-01	improved	79
P-01467	37%	S09	HY-01	improved	79
P-01479	34%	S15	DT-01	improved	84